{"id":6063,"date":"2023-05-09T08:00:00","date_gmt":"2023-05-09T08:00:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-to-proceed-with-communication-in-english-only\/"},"modified":"2023-05-09T08:00:00","modified_gmt":"2023-05-09T08:00:00","slug":"realheart-to-proceed-with-communication-in-english-only","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-to-proceed-with-communication-in-english-only\/","title":{"rendered":"Realheart to Proceed With Communication in English Only"},"content":{"rendered":"
Press Release 9 May, 2023<\/strong><\/div>\n

Scandinavian Real Heart AB has decided to continue to communicate only in English from the publication of the Q1 report on May 11, 2023. This means that all regulatory, including Market Abuse Regulation press releases, will be published only in English.<\/span><\/span><\/span><\/p>\n

The exception is annual reports, which according to current regulations must always be available in Swedish for Swedish-registered companies. An English version will also be available.<\/span><\/span><\/span><\/p>\n

\n

For more information please contact:<\/span><\/span><\/strong><\/span><\/p>\n

Ina Laura Perkins, CEO<\/span><\/span><\/p>\n

Phone: +46(0)70 406 49 21\u00a0<\/span><\/span><\/p>\n

E-mail: inalaura.perkins@realheart.se<\/span><\/span><\/p>\n

Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se<\/a><\/p>\n<\/div>\n

\n

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart<\/em><\/span><\/span>\u00ae<\/span><\/span><\/span><\/em> TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation.\u00a0<\/em><\/span><\/span>A unique concept in the medical technology world.<\/span><\/span><\/span><\/em><\/p>\n<\/div>\n